undefined undefined
NaN.000
NaN.00%
The latest update is out from Femasys (FEMY). Femasys Inc. has recently updated...
04-24 21:22
Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 20.83 percent increase over losses of $(0.24) per share from the same
03-29 11:38
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
03-22 02:30
Chardan Capital analyst Keay Nakae reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.
03-22 00:54
Gainers: SCWorx Corp (WORX) +52%. Taysha Gene Therapies (TSHA) +22%. XTL Biopharmaceuticals Ltd. (XTLB) +18%. TFF Pharmaceuticals (TFFP) +18%. Jaguar Health (JAGX) +16%. Losers: Lifecore Biomedical (L...
03-20 22:13
UC Davis Medical Center, a top regional and nationally ranked medical center, i...
01-26 09:00
- University of Utah Hospital, Lori Gawron, M.D. of the Obstetrics and Gynecolo...
01-23 09:30
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has made
2023-11-15 21:34
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
2023-10-04 20:25
Just because a business does not make any money, does not mean that the stock w...
2023-10-03 08:49